Herd Immunity to COVID-19.
作者信息
Kadkhoda Kamran
机构信息
Immunopathology Laboratory, Robert J. Tomsich Pathology & Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH.
出版信息
Am J Clin Pathol. 2021 Mar 15;155(4):471-472. doi: 10.1093/ajcp/aqaa272.
Abstract
摘要
相似文献
1
Herd Immunity to COVID-19.对新冠病毒的群体免疫
Am J Clin Pathol. 2021 Mar 15;155(4):471-472. doi: 10.1093/ajcp/aqaa272.
2
Herd immunization with childhood vaccination may provide protection against COVID-19.群体免疫接种儿童疫苗可能对预防 COVID-19 提供保护。
Acta Microbiol Immunol Hung. 2020 Sep 26;67(3):198-200. doi: 10.1556/030.2020.01207.
3
COVID-19 pandemic and vaccination build herd immunity.新冠疫情及疫苗接种构筑群体免疫。
Eur Rev Med Pharmacol Sci. 2021 Jan;25(2):577-579. doi: 10.26355/eurrev_202101_24613.
4
Endemic SARS-CoV-2 will maintain post-pandemic immunity.地方性 SARS-CoV-2 将维持大流行后的免疫。
Nat Rev Immunol. 2021 Mar;21(3):131-132. doi: 10.1038/s41577-020-00493-9.
5
Contact-adjusted Immunity Levels against SARS-CoV-2 in Korea and Prospects for Achieving Herd Immunity.韩国针对 SARS-CoV-2 的接触调整免疫水平和实现群体免疫的前景。
J Korean Med Sci. 2021 Oct 4;36(38):e272. doi: 10.3346/jkms.2021.36.e272.
6
COVID-19 vaccines and herd immunity: Perspectives, challenges and prospects.COVID-19 疫苗与群体免疫：观点、挑战与展望。
Malays J Pathol. 2021 Aug;43(2):203-217.
7
Are COVID vaccination programmes working? Scientists seek first clues.新冠疫苗接种计划是否有效？科学家们寻找初步线索。
Nature. 2021 Jan;589(7843):504-505. doi: 10.1038/d41586-021-00140-w.
8
Fast-spreading COVID variant can elude immune responses.快速传播的新冠病毒变种能够逃避免疫反应。
Nature. 2021 Jan;589(7843):500-501. doi: 10.1038/d41586-021-00121-z.
9
Five reasons why COVID herd immunity is probably impossible.新冠病毒群体免疫可能无法实现的五个原因。
Nature. 2021 Mar;591(7851):520-522. doi: 10.1038/d41586-021-00728-2.
10
On reaching herd immunity during the COVID-19 pandemic and further issues.关于在新冠疫情期间实现群体免疫及其他相关问题
J Med Virol. 2022 Jan;94(1):24-25. doi: 10.1002/jmv.27322. Epub 2021 Sep 12.
引用本文的文献
1
Importance of Targeted Communication Strategies During COVID-19 Vaccination Campaigns in Mozambique: Results of a Mixed-Methods Acceptability Study.莫桑比克新冠疫苗接种运动期间针对性沟通策略的重要性：一项混合方法可接受性研究的结果
Clin Infect Dis. 2025 Jul 22;80(Supplement_1):S66-S77. doi: 10.1093/cid/ciaf054.
2
The COVID-19 Vaccine Hesitancy Among Healthcare Workers: An Exploration of Hesitancy Reasons and Suggestions to Improve Vaccination Rates.医护人员对新冠疫苗的犹豫态度：犹豫原因探究及提高接种率的建议
Infect Dis Clin Microbiol. 2024 Jun 28;6(2):83-92. doi: 10.36519/idcm.2024.375. eCollection 2024 Jun.
3
Core health system measures response to COVID-19 among East Asian countries.东亚国家对 COVID-19 的核心卫生系统措施响应。
Front Public Health. 2024 Jun 3;12:1385291. doi: 10.3389/fpubh.2024.1385291. eCollection 2024.
4
Assessment of the Knowledge, Attitudes, and Practices of Indian Medical Students Towards Coronavirus Disease 2019 (COVID-19) After Two Doses of Vaccination and Their Approach Towards the Third (Booster) Dose.两剂疫苗接种后印度医学生对2019冠状病毒病（COVID-19）的知识、态度和行为评估以及他们对第三剂（加强）疫苗的态度
Cureus. 2024 Mar 5;16(3):e55588. doi: 10.7759/cureus.55588. eCollection 2024 Mar.
5
Pandemic fatigue, behavioral intention and predictors of COVID-19 vaccination among individuals living with HIV in Bench Sheko Zone, in Southern Ethiopia, application of TBP: a facility based cross sectional study.在埃塞俄比亚南部 Bench Sheko 地区，针对艾滋病毒感染者的大流行疲劳、行为意向和 COVID-19 疫苗接种预测因素：基于设施的横断面研究，应用 TBP。
Front Public Health. 2024 Feb 27;12:1305777. doi: 10.3389/fpubh.2024.1305777. eCollection 2024.
6
Disproportionate Rates of COVID-19 Among Black Canadian Communities: Lessons from a Cross-Sectional Study in the First Year of the Pandemic.加拿大黑人社区中新冠病毒病的不成比例发病率：大流行第一年横断面研究的经验教训。
J Racial Ethn Health Disparities. 2025 Feb;12(1):649-658. doi: 10.1007/s40615-023-01903-z. Epub 2024 Jan 22.
7
Factors associated with COVID-19 vaccination status: A cross-sectional study of California students in higher education.与新冠病毒疫苗接种状况相关的因素：一项对加利福尼亚州高等教育学生的横断面研究。
Prev Med Rep. 2023 Sep 1;36:102386. doi: 10.1016/j.pmedr.2023.102386. eCollection 2023 Dec.
8
COVID-19 transmission dynamics and the impact of vaccination: modelling, analysis and simulations.新型冠状病毒肺炎传播动力学及疫苗接种的影响：建模、分析与模拟
R Soc Open Sci. 2023 Jul 26;10(7):221656. doi: 10.1098/rsos.221656. eCollection 2023 Jul.
9
Utilizing nanozymes for combating COVID-19: advancements in diagnostics, treatments, and preventative measures.利用纳米酶防治 COVID-19：在诊断、治疗和预防措施方面的进展。
J Nanobiotechnology. 2023 Jun 21;21(1):200. doi: 10.1186/s12951-023-01945-9.
10
Clinical Course of 53 Previously Vaccinated Patients Admitted to the National Hospital in Warsaw, Poland with COVID-19 Between November 2021 and March 2022.2021 年 11 月至 2022 年 3 月期间，53 名曾在波兰华沙国家医院接种过疫苗的 COVID-19 患者的临床病程。
Med Sci Monit. 2023 Apr 29;29:e939841. doi: 10.12659/MSM.939841.
本文引用的文献
1
SARS-CoV-2 Antibody Responses Are Correlated to Disease Severity in COVID-19 Convalescent Individuals.SARS-CoV-2 抗体反应与 COVID-19 恢复期个体的疾病严重程度相关。
J Immunol. 2021 Jan 1;206(1):109-117. doi: 10.4049/jimmunol.2000898. Epub 2020 Nov 18.
2
Evidence of SARS-CoV-2 re-infection with a different genotype.新型冠状病毒 2 型（SARS-CoV-2）再次感染不同基因型的证据。
J Infect. 2021 Apr;82(4):84-123. doi: 10.1016/j.jinf.2020.11.011. Epub 2020 Nov 15.
3
Challenges in creating herd immunity to SARS-CoV-2 infection by mass vaccination.通过大规模疫苗接种建立对SARS-CoV-2感染的群体免疫面临的挑战。
Lancet. 2020 Nov 21;396(10263):1614-1616. doi: 10.1016/S0140-6736(20)32318-7. Epub 2020 Nov 4.
4
Genomic evidence for reinfection with SARS-CoV-2: a case study.基因组证据表明 SARS-CoV-2 再次感染：一项案例研究。
Lancet Infect Dis. 2021 Jan;21(1):52-58. doi: 10.1016/S1473-3099(20)30764-7. Epub 2020 Oct 12.
5
Antibody responses to SARS-CoV-2 in patients with COVID-19.新型冠状病毒肺炎（COVID-19）患者的 SARS-CoV-2 抗体反应。
Nat Med. 2020 Jun;26(6):845-848. doi: 10.1038/s41591-020-0897-1. Epub 2020 Apr 29.
6
Interim Estimates of 2019-20 Seasonal Influenza Vaccine Effectiveness - United States, February 2020.2019-20 季节性流感疫苗效力的临时估计-美国，2020 年 2 月。
MMWR Morb Mortal Wkly Rep. 2020 Feb 21;69(7):177-182. doi: 10.15585/mmwr.mm6907a1.
7
Vaccines: correlates of vaccine-induced immunity.疫苗：疫苗诱导免疫的相关因素。
Clin Infect Dis. 2008 Aug 1;47(3):401-9. doi: 10.1086/589862.
Zotero 插件